Home > Compound List > Product Information
Iron_Molecular_structure_CAS_7439-89-6)
Click picture or here to close

Iron

Catalog No. DB01592 Name DrugBank
CAS Number 7439-89-6 Website http://www.ualberta.ca/
M. F. Fe Telephone (780) 492-3111
M. W. 55.845 Fax (780) 492-1071
Purity Email david.wishart@ualberta.ca
Storage Chembase ID: 1370

SYNONYMS

IUPAC name
iron
IUPAC Traditional name
iron
Brand Name
Feratab
Slow Fe
Fergon
Feronate
Mol-Iron
Nephro-Fer
Feostat
Ircon
Hemocyte
Fe-40
Ferro-Time
Feosol
Yieronia
Ed-In-Sol
Siderol
Ferrousal
Ferretts
Ferro-Caps
Vitedyn-Slo
Fer-In-Sol

DATABASE IDS

CAS Number 7439-89-6
PubChem CID 23925
PubChem SID 46509190

PROPERTIES

DETAILS

Description (English)
Item Information
Drug Groups approved
Description A metallic element found in certain minerals, in nearly all soils, and in mineral waters. It is an essential constituent of hemoglobin, cytochrome, and other components of respiratory enzyme systems. Its chief functions are in the transport of oxygen to tissue (hemoglobin) and in cellular oxidation mechanisms. Depletion of iron stores may result in iron-deficiency anemia. Iron is used to build up the blood in anemia.
Indication Used in preventing and treating iron-deficiency anemia.
Pharmacology The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Toxicity Acute iron overdosage can be divided into four stages. In the first stage, which occurs up to six hours after ingestion, the principal symptoms are vomiting and diarrhea. Other symptoms include hypotension, tachycardia and CNS depression ranging from lethargy to coma. The second phase may occur at 6-24 hours after ingestion and is characterized by a temporary remission. In the third phase, gastrointestinal symptoms recur accompanied by shock, metabolic acidosis, coma, hepatic necrosis and jaundice, hypoglycemia, renal failure and pulmonary edema. The fourth phase may occur several weeks after ingestion and is characterized by gastrointestinal obstruction and liver damage. In a young child, 75 milligrams per kilogram is considered extremely dangerous. A dose of 30 milligrams per kilogram can lead to symptoms of toxicity. Estimates of a lethal dosage range from 180 milligrams per kilogram and upwards. A peak serum iron concentration of five micrograms or more per ml is associated with moderate to severe poisoning in many.
Affected Organisms
Humans and other mammals
Absorption The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
External Links
Wikipedia
RxList
PDRhealth
Drugs.com

REFERENCES